Opinion - NIH-funded research saved my life. Don’t take the chainsaw to it.
The NIH is considering a catastrophic cut to indirect cost reimbursements for public universities, which would hurt the ...
The Pioneer7h
Rare disorder: SC notice to drug manufacturer on availability of medicine
Can the medicine for treatment of rare disorder Spinal Muscular Atrophy (SMA) be made available at lower price in India if it is supplied to the neighbouring countries Pakistan and China at a cheaper ...
SC to govt: Why can't SMA med be as cheap in India as in Pakistan, China?
The Supreme Court of India seeks responses from the Centre and Roche on making the spinal muscular atrophy treatment drug ...
ET HealthWorld22h
SC to govt: Why can't SMA medicines be as cheap in India as in Pak, China?
The Supreme Court has sought responses from the Centre and pharmaceutical giant Roche on why their SMA treatment drug, ...
The American Journal of Managed Care1d
Key Considerations for Choosing the Right SMA Treatment
FDA-approved treatments for spinal muscular atrophy differ in their mechanisms of action, safety profiles, and administration ...
SMA News Today1d
Switching SMA treatments in UK based on practical needs: Study
Children with SMA in the U.K. can switch treatments based on practical needs and preferences without unexpected disease ...
Pharmabiz1d
Supreme Court issues notice to Roche on risiplam matter
The Supreme Court of India (SCI) has issued notice to Swiss pharma major F Hoffmann-La Roche Ltd, the manufacturer of spinal muscular atrophy (SMA) drug risdiplam and asked the company whether the ...
EuropaWire1d
Roche Propels Alzheimer’s Treatment Forward with Rapid Amyloid Clearance and Breakthrough Diagnostic Test
Roche presented new data at the AD/PD 2025 International Conference demonstrating that trontinemab, in its Phase Ib/IIa Brainshuttle™ AD study, ...